Novartis Chairman and CEO Daniel Vasella (photo) got a bit defensive at his company's annual meeting yesterday. Questioned about his pulling double duty as chairman and CEO, Vasella countered that firms with one person in each slot spend too much time and money settling conflicts between the two. Report